Plasma exchange with 5% albumin improved 90-day survival in selected patients with acute-on-chronic liver failure, offering the first positive survival study in the field.
MedPage Today on MSN
Albumin 5% Cut Mortality Rates in Sudden Liver Failure With Other Organ Failure
Treatment may be an effective bridge to transplantation for acute-on-chronic liver failure ...
Morning Overview on MSN
UC San Diego’s experimental pill just reversed the worst form of fatty liver disease in trial patients — shutting off the single enzyme driving fat buildup and inflammation
A single enzyme inside liver cells drives the production of triglycerides that, in excess, fuel the inflammation and scarring ...
In a study published in the Liver Transplantation journal, Mayo Clinic researchers have found that a new proactive treatment ...
Parade on MSN
From Patient to Nurse: How Hannah Fleming's Liver Transplant Inspired Her Life-Saving Career
Hannah Fleming, 28, shares how her own medical journey inspired her career.
Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease ...
Semaglutide significantly improved liver fibrosis and steatohepatitis resolution in MASH patients over 72 weeks compared to placebo. The study involved 800 patients receiving semaglutide and 400 ...
Gilead reports positive phase III IDEAL results as Livdelzi boosts ALP normalization in PBC patients, supporting regulatory discussions.
It's "not only a liver condition but also an important marker of heart disease risk,” says one of the study's authors.
Different types of liver disease are leading to distinct signatures of muscle loss, according to a new study that could help ...
A medication long used to help people breathe may soon help protect the liver as well. Researchers at the Medical University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results